ONC206, also known as ONC-206, is a small molecule anti-cancer drug that is currently in preclinical trials. It has shown promise in treating various types of cancer, including solid tumors and hematological malignancies.
Chemical Name
The chemical name of ONC206 is 2-(4-chlorophenyl)-N-(5-methyl-1H-pyrazol-3-yl)quinoline-4-carboxamide.
Molecular Formula
The molecular formula of ONC206 is C21H15ClN4O1.
Formula Weight
The formula weight of ONC206 is 380.82 g/mol.
CAS No.
The CAS number for ONC206 is 1638178-87-6.
Top Ten Keywords and Synonyms from Google
Health Benefits of ONC206
ONC206 is still undergoing preclinical trials, but it has shown promise in treating various types of cancer. In preclinical studies, ONC206 has been shown to inhibit the growth of cancer cells while leaving healthy cells unharmed. This makes it an attractive option for cancer treatment because it may result in fewer side effects than traditional chemotherapy.
Potential Effects
ONC206 has several potential effects, including:
Product Mechanism
ONC206 works by inhibiting a protein called c-Myc, which plays a role in the growth and proliferation of cancer cells. By inhibiting c-Myc, ONC206 suppresses the growth of cancer cells and induces apoptosis. The c-Myc protein is often overexpressed in cancer cells, making it an attractive target for cancer therapy.
Safety
ONC206 is still undergoing preclinical trials, and its safety profile is not fully understood. Further research is needed to determine the long-term safety of ONC206.
Side Effects
The side effects of ONC206 are not yet known, as it is still in preclinical trials.
Dosing Information
The dosing of ONC206 varies depending on the individual's condition and response to treatment. As it is still in preclinical trials, the optimal dosage has not been determined.
Conclusion
ONC206 is a novel anti-cancer drug that shows promising results in preclinical trials. It works by inhibiting the c-Myc protein, leading to inhibition of cancer cell growth and induction of apoptosis. ONC206 may have fewer side effects than traditional chemotherapy because it specifically targets cancer cells while leaving healthy cells unharmed. While still undergoing preclinical trials, ONC206 offers hope for individuals with various types of cancer. If you are experiencing symptoms of cancer or other health conditions, it is important to seek medical attention and follow the guidance of healthcare professionals.